Coronary Artery Disease Clinical Trials in Wichita, Kansas

5 studies are recruiting for coronary artery disease in Wichita, Kansas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Virtue® SAB in the Treatment of Coronary ISR Trial

   A prospective, multi-center, single-blind, randomized (1:1), non-inferiority study comparing clinical outcomes of the Virtue® Sirolimus AngioInfusion™ Balloon (SAB) to the AGENT™ Paclitaxel Drug-Coated Balloon (DCB) in the treatment of coronary artery in-stent restenosis (ISR).

   Stage

   Not phased

   Ages

   18 and older

   Site

   Ascension Via Christi Saint Francis, Wichita, Kansas

   Locations

   22 in total

   Run by

   Orchestra BioMed, Inc

   See if you can join NCT07045194 on ClinicalTrials.gov

2. Prevail Global Study

   The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Ascension Via Christi Saint Francis, Wichita, Kansas

   Locations

   79 in total

   Run by

   Medtronic Vascular

   See if you can join NCT06535854 on ClinicalTrials.gov

3. Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP

   The purpose of this Phase 2b study is to investigate the efficacy in reducing systemic inflammation, safety, tolerability, and dose response of five doses of YMI024, as compared to placebo in adult participants with stable coronary artery disease (CAD) and residual inflammatory risk defined by elev…

   Stage

   Phase 2

   Ages

   18 to 80

   Site

   Alliance for Multispecialty Research, Wichita, Kansas

   Locations

   23 in total

   Run by

   Novartis Pharmaceuticals

   See if you can join NCT07830719 on ClinicalTrials.gov

4. Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

   The purpose of the study is to assess the safety and efficacy of the Orsiro® Mission 48- mm Sirolimus-Eluting Coronary Stent System in the treatment of subjects with atherosclerotic lesion(s) >36 mm and ≤ 44 mm in length (by visual estimate) in the native coronary arteries with a reference vessel d…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Ascension Via Christi Hospitals Wichita, Wichita, Kansas

   Locations

   23 in total

   Run by

   Teleflex

   See if you can join NCT06779630 on ClinicalTrials.gov

5. Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

   Patients undergoing transcatheter aortic valve replacement (TAVR) often have concomitant coronary artery disease (CAD) which may adversely affect prognosis. There is uncertainty about the benefits and the optimal timing of revascularization for such patients. There is currently clinical equipoise r…

   Stage

   Not phased

   Ages

   Any age

   Site

   Cardiovascular Research Institute of Kansas, Wichita, Kansas

   Locations

   72 in total

   Run by

   University of British Columbia

   See if you can join NCT04634240 on ClinicalTrials.gov